Roundtable: Cell and Gene Therapy Manufacturing Panel at Advanced Therapies Week 2024
Summary: Isabel Cameron with BioPharma Reporter hosted a roundtable discussion that covered all things cell and gene therapy manufacturing. Catalent expert George Buchman, Ph.D., offers insights on key challenges with scaling up production for gene therapies, complexities in the supply chain, regulatory considerations and overall reflections on the industry, progress and future.
Key Learnings:
- The global cell and gene therapy market is rapidly growing with therapies that have the potential to transform how we treat and cure diseases
- However, these treatments pose significant manufacturing challenges
- This panel aims to shed light on the most pressing and difficult issues within the industry and how we might solve them